Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy - Concepedia

Concepedia

Publication | Closed Access

Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy

150

Citations

45

References

2021

Year

Liguo Wang, Xuejing Shao, Tianbai Zhong, Yue Wu, Aixiao Xu, Xiuyun Sun, Hongying Gao, Yongbo Liu, Tianlong Lan, Tong Yan,

Nature Chemical Biology

Aml Differentiation TherapyReceptor Tyrosine KinaseCell BiologyMedicineRadiation OncologyCell SignalingNovel Therapy

References

	Year	Citations

Page 1